2 hours Leerink Partnrs Lowers Earnings Estimates for Pyxis OncologyMarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2024 earnings per share (EPS) estimates for Pyxis Oncology in a research note issued to investors on Tuesday, October 15th. Leerink Partnrs analyst J. La…
Earnings · Nasdaq 100 · Science
X